Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Sandeep Soni, MD
Researcher Executive Director
CRISPR Therapeutics, Inc.
610 Main Street
Cambridge, Massachusetts, United States
Sandeep Soni, MD, is the Executive Director at CRISPR Therapeutics, Inc. His expertise includes bone marrow transplantation (HSCT), cellular therapies and gene therapy for malignant and non-malignant blood disorders and clinical development of programs. He is also an expert of lentiviral vectors, Crispr- Cas9 gene editing, stem cell transplant, T-cell therapies and regulatory/safety aspects of gene-therapies.
Areas of Interest-
– Cellular Therapy
– Gene Therapy
– Stem Cell Transplant
– Sickle Cell Disease
– Thalassemia
– Reduced Intensity Conditioning
Clinical Focus-
– Hematology/Oncology
– Stem Cell Transplant and Gene Therapy
Related Content
-
Froedtert Hospital, Sickle Cell ClinicSickle cell disease (SCD) is a genetic d...
-
Shengdar Q. Tsai, PhDDr. Shengdar Q. Tsai is an assistant mem...
-
Dyspareunia is Associated With Chronic Pain in Premenopausal Women With Sickle Cell DiseaseObjectives: Pain is common in women wit...
-
Opioid Abuse Backlash Could Hurt Sickle Cell Patients’ Medication Needs, Some FearWith drug overdoses now the leading caus...
-
Hannah S. Lichtsinn, MDHannah S. Lichtsinn is MD in internal me...
-
Webinar Series: Sickle Cell Science: Path to Progress – Serving the Sickle Cell Disease Community Here and Abr...To commemorate Sickle Cell Awareness Mon...
-
Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful CrisesOBJECTIVES: Sickle cell disease is the ...